Study Protocol for the DETECTIVE Study

An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer

T. B. L. Lam* (Corresponding Author), S. MacLennan, K. Plass, P. M. Willemse, M. D. Mason, P. Cornford, J. Donaldson, N. Davig, P. Dell'Oglio, C. Fankauser, N. Grivas, A. Ingels, M. Lardas, M. Liew, K. Pang, C. Paterson, M. I. Omar, F. Zattoni, T. Buddingh, T. van den Broeck & 20 others M. Cumberbatch, N. Fossati, T. Gross, L. Moris, I.G. Schoots, R.C.N. van den Bergh, E. Briers, L. Bourke, M. De Santis, S. Gillessen, J.P. Grummet, A.M. Henry, H.G. van der Poel, T.H. van der Kwast, O. Rouvière, D. Tilki, T. Wiegel, James N'Dow, Hendrik Van Poppel, Nicolas Mottet

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are a recognised management option for men with localised low-risk prostate cancer. However, there is uncertainty due to heterogeneity of patient selection criteria, follow-up and monitoring characteristics, reclassification thresholds, and which outcome measures should be prioritised. This protocol describes a study led by the European Association of Urology (EAU) Prostate Cancer Guidelines Panel in conjunction with other guideline organisations and societies* to develop consensus statements for all domains of deferred active treatment. The project is divided into 3 sequential phases: (1) Systematic review of studies reporting on DAT in order to summarise and define range of heterogeneity regarding all domains; (2) Two-round Delphi online survey involving a large, international panel of healthcare professionals (HCPs) and patients to initiate consensus; and (3) Consensus group meeting involving representatives from HCP and patient stakeholder groups to finalise the consensus process. The consensus statements are expected to be adopted by clinical practice guidelines in order to standardise and guide practice for clinicians and researchers until better evidence emerges.

Patient summary: We describe a project aimed at standardising elements of practice in active surveillance/monitoring for early localised prostate cancer, because currently there is great variation and uncertainty regarding how best to conduct them. This will be achieved through a structured process of agreement (i.e. consensus) amongst a large, international panel of healthcare professionals and patients.
Original languageEnglish
Pages (from-to)699-702
Number of pages4
JournalEuropean Urology
Volume75
Issue number4
Early online date22 Nov 2018
DOIs
Publication statusPublished - Apr 2019

Fingerprint

Prostatic Neoplasms
Consensus
Delivery of Health Care
Patient Selection
Uncertainty
Therapeutics
Guidelines
Group Processes
Practice Guidelines
Research Personnel
Outcome Assessment (Health Care)
Organizations

ASJC Scopus subject areas

  • Urology

Cite this

Study Protocol for the DETECTIVE Study : An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. / Lam, T. B. L. (Corresponding Author); MacLennan, S.; Plass, K.; Willemse, P. M.; Mason, M. D.; Cornford, P.; Donaldson, J.; Davig, N.; Dell'Oglio, P.; Fankauser, C.; Grivas, N.; Ingels, A.; Lardas, M.; Liew, M.; Pang, K.; Paterson, C.; Omar, M. I.; Zattoni, F.; Buddingh, T.; van den Broeck, T.; Cumberbatch, M.; Fossati, N.; Gross, T.; Moris, L.; Schoots, I.G.; van den Bergh, R.C.N.; Briers, E.; Bourke, L.; De Santis, M.; Gillessen, S.; Grummet, J.P.; Henry, A.M.; van der Poel, H.G.; van der Kwast, T.H.; Rouvière, O.; Tilki, D.; Wiegel, T.; N'Dow, James; Van Poppel, Hendrik ; Mottet, Nicolas.

In: European Urology, Vol. 75, No. 4, 04.2019, p. 699-702.

Research output: Contribution to journalArticle

Lam, TBL, MacLennan, S, Plass, K, Willemse, PM, Mason, MD, Cornford, P, Donaldson, J, Davig, N, Dell'Oglio, P, Fankauser, C, Grivas, N, Ingels, A, Lardas, M, Liew, M, Pang, K, Paterson, C, Omar, MI, Zattoni, F, Buddingh, T, van den Broeck, T, Cumberbatch, M, Fossati, N, Gross, T, Moris, L, Schoots, IG, van den Bergh, RCN, Briers, E, Bourke, L, De Santis, M, Gillessen, S, Grummet, JP, Henry, AM, van der Poel, HG, van der Kwast, TH, Rouvière, O, Tilki, D, Wiegel, T, N'Dow, J, Van Poppel, H & Mottet, N 2019, 'Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer', European Urology, vol. 75, no. 4, pp. 699-702. https://doi.org/10.1016/j.eururo.2018.11.009
Lam, T. B. L. ; MacLennan, S. ; Plass, K. ; Willemse, P. M. ; Mason, M. D. ; Cornford, P. ; Donaldson, J. ; Davig, N. ; Dell'Oglio, P. ; Fankauser, C. ; Grivas, N. ; Ingels, A. ; Lardas, M. ; Liew, M. ; Pang, K. ; Paterson, C. ; Omar, M. I. ; Zattoni, F. ; Buddingh, T. ; van den Broeck, T. ; Cumberbatch, M. ; Fossati, N. ; Gross, T. ; Moris, L. ; Schoots, I.G. ; van den Bergh, R.C.N. ; Briers, E. ; Bourke, L. ; De Santis, M. ; Gillessen, S. ; Grummet, J.P. ; Henry, A.M. ; van der Poel, H.G. ; van der Kwast, T.H. ; Rouvière, O. ; Tilki, D. ; Wiegel, T. ; N'Dow, James ; Van Poppel, Hendrik ; Mottet, Nicolas. / Study Protocol for the DETECTIVE Study : An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer. In: European Urology. 2019 ; Vol. 75, No. 4. pp. 699-702.
@article{2553c3d4dd7948109cdda268bb94753a,
title = "Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer",
abstract = "Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are a recognised management option for men with localised low-risk prostate cancer. However, there is uncertainty due to heterogeneity of patient selection criteria, follow-up and monitoring characteristics, reclassification thresholds, and which outcome measures should be prioritised. This protocol describes a study led by the European Association of Urology (EAU) Prostate Cancer Guidelines Panel in conjunction with other guideline organisations and societies* to develop consensus statements for all domains of deferred active treatment. The project is divided into 3 sequential phases: (1) Systematic review of studies reporting on DAT in order to summarise and define range of heterogeneity regarding all domains; (2) Two-round Delphi online survey involving a large, international panel of healthcare professionals (HCPs) and patients to initiate consensus; and (3) Consensus group meeting involving representatives from HCP and patient stakeholder groups to finalise the consensus process. The consensus statements are expected to be adopted by clinical practice guidelines in order to standardise and guide practice for clinicians and researchers until better evidence emerges.Patient summary: We describe a project aimed at standardising elements of practice in active surveillance/monitoring for early localised prostate cancer, because currently there is great variation and uncertainty regarding how best to conduct them. This will be achieved through a structured process of agreement (i.e. consensus) amongst a large, international panel of healthcare professionals and patients.",
author = "Lam, {T. B. L.} and S. MacLennan and K. Plass and Willemse, {P. M.} and Mason, {M. D.} and P. Cornford and J. Donaldson and N. Davig and P. Dell'Oglio and C. Fankauser and N. Grivas and A. Ingels and M. Lardas and M. Liew and K. Pang and C. Paterson and Omar, {M. I.} and F. Zattoni and T. Buddingh and {van den Broeck}, T. and M. Cumberbatch and N. Fossati and T. Gross and L. Moris and I.G. Schoots and {van den Bergh}, R.C.N. and E. Briers and L. Bourke and {De Santis}, M. and S. Gillessen and J.P. Grummet and A.M. Henry and {van der Poel}, H.G. and {van der Kwast}, T.H. and O. Rouvi{\`e}re and D. Tilki and T. Wiegel and James N'Dow and {Van Poppel}, Hendrik and Nicolas Mottet",
year = "2019",
month = "4",
doi = "10.1016/j.eururo.2018.11.009",
language = "English",
volume = "75",
pages = "699--702",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "4",

}

TY - JOUR

T1 - Study Protocol for the DETECTIVE Study

T2 - An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer

AU - Lam, T. B. L.

AU - MacLennan, S.

AU - Plass, K.

AU - Willemse, P. M.

AU - Mason, M. D.

AU - Cornford, P.

AU - Donaldson, J.

AU - Davig, N.

AU - Dell'Oglio, P.

AU - Fankauser, C.

AU - Grivas, N.

AU - Ingels, A.

AU - Lardas, M.

AU - Liew, M.

AU - Pang, K.

AU - Paterson, C.

AU - Omar, M. I.

AU - Zattoni, F.

AU - Buddingh, T.

AU - van den Broeck, T.

AU - Cumberbatch, M.

AU - Fossati, N.

AU - Gross, T.

AU - Moris, L.

AU - Schoots, I.G.

AU - van den Bergh, R.C.N.

AU - Briers, E.

AU - Bourke, L.

AU - De Santis, M.

AU - Gillessen, S.

AU - Grummet, J.P.

AU - Henry, A.M.

AU - van der Poel, H.G.

AU - van der Kwast, T.H.

AU - Rouvière, O.

AU - Tilki, D.

AU - Wiegel, T.

AU - N'Dow, James

AU - Van Poppel, Hendrik

AU - Mottet, Nicolas

PY - 2019/4

Y1 - 2019/4

N2 - Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are a recognised management option for men with localised low-risk prostate cancer. However, there is uncertainty due to heterogeneity of patient selection criteria, follow-up and monitoring characteristics, reclassification thresholds, and which outcome measures should be prioritised. This protocol describes a study led by the European Association of Urology (EAU) Prostate Cancer Guidelines Panel in conjunction with other guideline organisations and societies* to develop consensus statements for all domains of deferred active treatment. The project is divided into 3 sequential phases: (1) Systematic review of studies reporting on DAT in order to summarise and define range of heterogeneity regarding all domains; (2) Two-round Delphi online survey involving a large, international panel of healthcare professionals (HCPs) and patients to initiate consensus; and (3) Consensus group meeting involving representatives from HCP and patient stakeholder groups to finalise the consensus process. The consensus statements are expected to be adopted by clinical practice guidelines in order to standardise and guide practice for clinicians and researchers until better evidence emerges.Patient summary: We describe a project aimed at standardising elements of practice in active surveillance/monitoring for early localised prostate cancer, because currently there is great variation and uncertainty regarding how best to conduct them. This will be achieved through a structured process of agreement (i.e. consensus) amongst a large, international panel of healthcare professionals and patients.

AB - Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are a recognised management option for men with localised low-risk prostate cancer. However, there is uncertainty due to heterogeneity of patient selection criteria, follow-up and monitoring characteristics, reclassification thresholds, and which outcome measures should be prioritised. This protocol describes a study led by the European Association of Urology (EAU) Prostate Cancer Guidelines Panel in conjunction with other guideline organisations and societies* to develop consensus statements for all domains of deferred active treatment. The project is divided into 3 sequential phases: (1) Systematic review of studies reporting on DAT in order to summarise and define range of heterogeneity regarding all domains; (2) Two-round Delphi online survey involving a large, international panel of healthcare professionals (HCPs) and patients to initiate consensus; and (3) Consensus group meeting involving representatives from HCP and patient stakeholder groups to finalise the consensus process. The consensus statements are expected to be adopted by clinical practice guidelines in order to standardise and guide practice for clinicians and researchers until better evidence emerges.Patient summary: We describe a project aimed at standardising elements of practice in active surveillance/monitoring for early localised prostate cancer, because currently there is great variation and uncertainty regarding how best to conduct them. This will be achieved through a structured process of agreement (i.e. consensus) amongst a large, international panel of healthcare professionals and patients.

UR - http://www.scopus.com/inward/record.url?scp=85062005138&partnerID=8YFLogxK

UR - http://www.mendeley.com/research/study-protocol-detective-study-international-collaborative-study-develop-consensus-statements-deferr

UR - https://abdn.pure.elsevier.com/en/en/researchoutput/study-protocol-for-the-detective-study(2553c3d4-dd79-4810-9cdd-a268bb94753a).html

U2 - 10.1016/j.eururo.2018.11.009

DO - 10.1016/j.eururo.2018.11.009

M3 - Article

VL - 75

SP - 699

EP - 702

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 4

ER -